{"product_id":"vascular-patches-market-by-material-biologic-synthetic-application-open-repair-of-abdominal-aortic-aneurysm-congenital-heart-disease-carotid-endarterectomy-end-user-hospitals-ambulatory-surgical-centers-global-forecast-to-2027","title":"Vascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2027","description":"\u003cp\u003eVascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2027\u003c\/p\u003e\n\n\u003cp\u003eThe global vascular patches market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period. Market growth is driven by factors such as the rising incidence of CVD, the rise in the volume of surgical procedures, coupled with the increasing adoption of biological patches for vascular surgeries.\u003c\/p\u003e\n\n\u003cp\u003e“The biologic vascular patches held the largest share of the vascular patches market, by material”\u003c\/p\u003e\n\n\u003cp\u003eBased on material, the global vascular patches market is segmented into biological and synthetic vascular patches. Biologic vascular patches held a significant share in the market. It is also the fastest-growing material segment in this market. Growth in this segment is primarily driven by the advantages offered by the biologic patches over their synthetic counterparts.\u003c\/p\u003e\n\n\u003cp\u003e“The vascular bypass surgery segment is the fastest growing segment of the vascular patches market, by application”\u003c\/p\u003e\n\n\u003cp\u003eBased on application, the vascular patches market is segmented into carotid endarterectomy (CEA), open repair of abdominal aortic aneurysm (AAA), congenital heart diseases, vascular bypass surgery, and other applications. The vascular bypass surgery is expected to witness the fastest growth during the forecast period. The high growth rate of vascular bypass surgery can be attributed to the availability of reimbursement in emerging and developed economies.\u003c\/p\u003e\n\n\u003cp\u003e“Among the end users, the hospitals segment is anticipated to register the highest growth during the forecast period”\u003c\/p\u003e\n\n\u003cp\u003eBased on end users, the vascular patches market is segmented into hospitals and ambulatory surgical centers. The hospitals segment is anticipated to witness growth at the highest rate during the forecast period. The growth can be attributed to the increasing number of hospitals offering better healthcare services and infrastructure.\u003c\/p\u003e \n\n\u003cp\u003e“The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”\u003c\/p\u003e\n\n\u003cp\u003eThe global vascular patches market is segmented into four regions - North America, Europe, the Asia Pacific, and Rest of the World. The Asia Pacific region is expected to witness the highest growth in the vascular patches market during the forecast period. The high growth in this region can primarily be attributed to the large number of target population, and improved healthcare infrastructures in Southeast Asian countries.\u003c\/p\u003e\n\n\u003cp\u003eThe primary interviews conducted for this report can be categorized as follows:\u003c\/p\u003e\n\n\u003cp\u003eBy Company Type: Tier 1 - 30%, Tier 2 - 45%, and Tier 3 - 25%\u003c\/p\u003e\n\n\u003cp\u003eBy Designation: C-level - 28%, D-level - 32%, and Others - 40%\u003c\/p\u003e\n\n\u003cp\u003eBy Region: North America - 35%, Europe - 21%, Asia Pacific - 28%, Rest of the World – 16%\u003c\/p\u003e\n\n\u003cp\u003eLists of Companies Profiled in the Report:\u003c\/p\u003e\n\n\u003cp\u003eBaxter International, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eLeMaitre Vascular, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eW. L. Gore \u0026amp; Associates, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eGetinge AB (Sweden)\u003c\/p\u003e\n\n\u003cp\u003eB Braun (Germany)\u003c\/p\u003e\n\n\u003cp\u003eArtivion, Inc (US)\u003c\/p\u003e\n\n\u003cp\u003eEdwards Lifesciences Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eAziyo Biologics, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eTerumo Corporation (Japan)\u003c\/p\u003e\n\n\u003cp\u003eBD (US)\u003c\/p\u003e\n\n\u003cp\u003eLabcor Laboratórios Ltda. (Brazil)\u003c\/p\u003e\n\n\u003cp\u003eVUP Medical (Czech Republic)\u003c\/p\u003e\n\n\u003cp\u003eAegis Lifesciences (India)\u003c\/p\u003e\n\n\u003cp\u003eSynkroMax Biotech Pvt. Ltd. (India)\u003c\/p\u003e\n\n\u003cp\u003eResearch Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a detailed picture of the global vascular patches market. It aims at estimating the size and future growth potential of the market across different segments, such as material, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.\u003c\/p\u003e\n\n\u003cp\u003eKey Benefits of Buying the Report:\u003c\/p\u003e\n\n\u003cp\u003eThe report will help market leaders\/new entrants by providing them with the closest approximations of the revenue numbers for the overall vascular patches market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"November, 2022 \/ 133 Pages \/ MCW16239012","offer_id":47654090637618,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/vascular-patches-market-by-material-biologic-synthetic-application-open-repair-of-abdominal-aortic-aneurysm-congenital-heart-disease-carotid-endarterectomy-end-user-hospitals-ambulatory-surgical-centers-global-forecast-to-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}